Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

547 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Higher Levels of Secretory IgA Are Associated with Low Disease Activity Index in Patients with Reactive Arthritis and Undifferentiated Spondyloarthritis.
Salas-Cuestas F, Bautista-Molano W, Bello-Gualtero JM, Arias I, Castillo DM, Chila-Moreno L, Valle-Oñate R, Herrera D, Romero-Sánchez C. Salas-Cuestas F, et al. Among authors: herrera d. Front Immunol. 2017 Apr 27;8:476. doi: 10.3389/fimmu.2017.00476. eCollection 2017. Front Immunol. 2017. PMID: 28496443 Free PMC article.
Circulating rotavirus-specific T cells have a poor functional profile.
Parra M, Herrera D, Jácome MF, Mesa MC, Rodríguez LS, Guzmán C, Angel J, Franco MA. Parra M, et al. Among authors: herrera d. Virology. 2014 Nov;468-470:340-350. doi: 10.1016/j.virol.2014.08.020. Epub 2014 Sep 18. Virology. 2014. PMID: 25238642 Free article.
Efficacy and safety of dabrafenib-trametinib in the treatment of unresectable or metastatic melanoma with BRAF V600 mutation: A systematic review and network meta-analysis.
Garzón-Orjuela N, Prieto-Pinto L, Lasalvia P, Herrera D, Castrillón J, González-Bravo D, Castañeda-Cardona C, Rosselli D. Garzón-Orjuela N, et al. Among authors: herrera d. Dermatol Ther. 2020 Aug 5:e14135. doi: 10.1111/dth.14135. Online ahead of print. Dermatol Ther. 2020. PMID: 32761749 Review.
Efficacy and safety of dabrafenib-trametinib in the treatment of unresectable advanced/metastatic melanoma with BRAF-V600 mutation: A systematic review and network meta-analysis.
Garzón-Orjuela N, Prieto-Pinto L, Lasalvia P, Herrera D, Castrillón J, González-Bravo D, Castañeda-Cardona C, Rosselli D. Garzón-Orjuela N, et al. Among authors: herrera d. Dermatol Ther. 2020 Mar;33(2):e13145. doi: 10.1111/dth.13145. Epub 2019 Nov 14. Dermatol Ther. 2020. PMID: 31664762 Review.
Cost-Effectiveness of the Dabrafenib Schedule in Combination With Trametinib Compared With Other Targeted Therapies, Immunotherapy, and Dacarbazine for the Treatment of Unresectable or Metastatic Melanoma With BRAFV600 Mutation in Colombia.
Gil-Rojas Y, Lasalvia P, Hernández F, Castañeda-Cardona C, Castrillón-Correa J, Herrera D, Rosselli D. Gil-Rojas Y, et al. Among authors: herrera d. Value Health Reg Issues. 2021 Dec;26:182-190. doi: 10.1016/j.vhri.2021.04.008. Epub 2021 Oct 18. Value Health Reg Issues. 2021. PMID: 34673349 Free article.
547 results